Dr. Stacy’s research focuses on the development of non-invasive imaging strategies to increase our understanding of vascular diseases and improve patient outcomes. His imaging work involves analyzing the pathophysiology of conditions that include peripheral artery disease, atherosclerosis, diabetes mellitus, and chemotherapy-induced vascular toxicity.

Dr. Stacy’s laboratory specializes in the use of multimodality imaging techniques and medical image processing, with a particular emphasis on molecular imaging strategies, to quantify and monitor cardiovascular diseases and their complications. He incorporates a wide range of imaging modalities in his research program including PET/CT, microPET/CT, SPECT/CT, CT angiography and MRI imaging in pre-clinical models and clinical populations.


  • Bachelor of Science: The Ohio State University
  • PhD: University of Toledo
  • Postdoctoral Fellowship: Yale University School of Medicine

Research Interests

  • Nuclear and molecular imaging
  • Medical image processing
  • Cardiovascular physiology
  • Peripheral artery disease
  • Skeletal muscle perfusion
  • Vascular biology

Professional Activities

  • Fellow, American Heart Association
  • Member, American Heart Association’s Peripheral Vascular Disease Council

Honors and Awards

  • Recipient of the H. William Strauss Best Technical Research Paper from the Journal of Nuclear Cardiology Editorial Board, 2021

Current Funding

  • NIH R01 HL135103
    Radiotracer-Based Imaging for Quantitative Assessment of Skeletal Muscle Perfusion in Peripheral Artery Disease